New activated macrophage-specific antigen (AcM.1) detected by a monoclonal antibody has been described. The AcM.1 antigen was only detectable on activated macrophages induced by pyran and Corynebacterium parvum but not on resident or thioglycollate medium (TGC), proteose-peptone, and mineral oil-elicited macrophages, and not on blood monocytes and neutrophils. Activated macrophages induced by pyran and C. parvum, as expected, exhibited tumor cytotoxicity, whereas TGC-elicited macrophages did not show any cytotoxicity. Moreover, pretreatment of pyran-activated peritoneal exudate cells with AcM.1 antibody plus complement abolished approximately 80% cytotoxicity. Thus, this AcM.1 antigen detected by a monoclonal antibody is the first unique marker of activated tumoricidal macrophages and should provide a useful probe for investigating the mechanisms of activation or differentiation of macrophages.
Skip Nav Destination
Article navigation
1 October 1982
Article|
October 01 1982
Establishment of a hybridoma secreting a monoclonal antibody specific for activated tumoricidal macrophages.
T Taniyama
T Watanabe
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1982) 156 (4): 1286–1291.
Citation
T Taniyama, T Watanabe; Establishment of a hybridoma secreting a monoclonal antibody specific for activated tumoricidal macrophages.. J Exp Med 1 October 1982; 156 (4): 1286–1291. doi: https://doi.org/10.1084/jem.156.4.1286
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement